181
Participants
Start Date
June 19, 2015
Primary Completion Date
March 21, 2017
Study Completion Date
August 31, 2023
TAF
TAF 25 mg tablet administered orally once daily
TDF
TDF 300 mg tablet administered orally once daily
TAF Placebo
TAF placebo tablet administered orally once daily
TDF Placebo
TDF placebo tablet administered orally once daily
Beijing Ditan Hospital, Beijing
PLA 302 Hospital, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Beijing Youan Hospital, Capital Medical University, Beijing
Shengjing Hospital of China Medical University, Shenyang
The Sixth People's Hospital of Shenyang, Shenyang
1st Hospital Jilin University, Jilin
Ruijin Hospital, JiaoTong University School of Medicine, Shanghai
Shanghai Public Health Clinical Center, Shanghai
85 Hospital of People's Liberation Army, Shanghai
2nd Hospital of Nanjing City, Nanjing
Jiangsu Province People's Hospital, Nanjing
Jinan Infectious Disease Hospital, Jinan
The First Affiliated Hospital of Nanchang University, Jiangxi
Xianya Hospital, Central South University, Changsha
The Second Xiangya Hospital of Central South University, Hunan
Guangzhou Eighth People's Hospital, Guangzhou
Nanfang Medical University, Nanfang Hospital, Guangzhou
No. 3 Hospital, Zhongshan Medical University, Guangzhou
The Affiliated Hospital of Guiyang Medical College, Guiyang
The People's Hospital of Hainan Province, Haikou
West China Hospital, Sichuan University, Sichuan
1st Affiliated Hospital Kunming Medical College, Yunnan
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
3rd Hospital of Hebei Medical University, Shijiazhuang
Lead Sponsor
Gilead Sciences
INDUSTRY